Concepedia

Itaru Miyashita

IM

3

Publications

87

Citations

3

H-Index

2006

Active since

Affiliations

Kissei Pharmaceutical (Japan)(Current)

Juntendo University

Itaru Miyashita is an author at Kissei Pharmaceutical (Japan) specializing in pharmacokinetics, medicine, and pharmacology.

Top concepts

Publications per year

2006–2019

3

Publications

3

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

Eric Angevin, Nicolás Isambert, V. Trillet-Lenoir et al. · British Journal of Cancer · 2017 · 60 citations · Full text

Pharmacokinetic Profile of Silodosin in Clinical Practice

Tomoji Shimizu, Itaru Miyashita, Yasuhito MATSUBARA et al. · YAKUGAKU ZASSHI · 2006 · 14 citations · Full text

, , +3

Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma

Masayuki Takeda, Yuichiro Ohe, Hidehito Horinouchi et al. · Lung Cancer · 2019 · 13 citations

Rows per page

1–3 of 3